rs5943427

Variant summary

Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong

The NM_001318510.2(ACSL4):​c.-66+3029C>G variant causes a intron change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.52 ( 11077 hom., 16863 hem., cov: 23)
Failed GnomAD Quality Control

Consequence

ACSL4
NM_001318510.2 intron

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.154

Publications

2 publications found
Variant links:
Genes affected
ACSL4 (HGNC:3571): (acyl-CoA synthetase long chain family member 4) The protein encoded by this gene is an isozyme of the long-chain fatty-acid-coenzyme A ligase family. Although differing in substrate specificity, subcellular localization, and tissue distribution, all isozymes of this family convert free long-chain fatty acids into fatty acyl-CoA esters, and thereby play a key role in lipid biosynthesis and fatty acid degradation. This isozyme preferentially utilizes arachidonate as substrate. The absence of this enzyme may contribute to the cognitive disability or Alport syndrome. Alternative splicing of this gene generates multiple transcript variants. [provided by RefSeq, Jan 2016]
ACSL4 Gene-Disease associations (from GenCC):
  • non-syndromic X-linked intellectual disability
    Inheritance: XL Classification: DEFINITIVE, MODERATE, SUPPORTIVE Submitted by: Orphanet, ClinGen, Illumina
  • intellectual disability, X-linked 63
    Inheritance: XL Classification: STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_001318510.2, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -4 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.95).

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001318510.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ACSL4
NM_001318510.2
MANE Select
c.-66+3029C>G
intron
N/ANP_001305439.1O60488-2
ACSL4
NM_001318509.2
c.-234+3029C>G
intron
N/ANP_001305438.1O60488-1
ACSL4
NM_001437245.1
c.-120+3029C>G
intron
N/ANP_001424174.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ACSL4
ENST00000672401.1
MANE Select
c.-66+3029C>G
intron
N/AENSP00000500273.1O60488-2
ACSL4
ENST00000348502.10
TSL:1
c.-63+3029C>G
intron
N/AENSP00000262835.7O60488-2
ACSL4
ENST00000340800.7
TSL:5
c.-252+3029C>G
intron
N/AENSP00000339787.2O60488-1

Frequencies

GnomAD3 genomes
AF:
0.520
AC:
57676
AN:
110921
Hom.:
11076
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.524
Gnomad AMI
AF:
0.443
Gnomad AMR
AF:
0.371
Gnomad ASJ
AF:
0.575
Gnomad EAS
AF:
0.149
Gnomad SAS
AF:
0.423
Gnomad FIN
AF:
0.516
Gnomad MID
AF:
0.644
Gnomad NFE
AF:
0.575
Gnomad OTH
AF:
0.531
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
Data not reliable, filtered out with message: InbreedingCoeff
AF:
0.520
AC:
57710
AN:
110974
Hom.:
11077
Cov.:
23
AF XY:
0.508
AC XY:
16863
AN XY:
33218
show subpopulations
African (AFR)
AF:
0.524
AC:
15993
AN:
30508
American (AMR)
AF:
0.370
AC:
3881
AN:
10478
Ashkenazi Jewish (ASJ)
AF:
0.575
AC:
1511
AN:
2629
East Asian (EAS)
AF:
0.148
AC:
525
AN:
3546
South Asian (SAS)
AF:
0.422
AC:
1136
AN:
2689
European-Finnish (FIN)
AF:
0.516
AC:
3003
AN:
5815
Middle Eastern (MID)
AF:
0.653
AC:
139
AN:
213
European-Non Finnish (NFE)
AF:
0.575
AC:
30419
AN:
52914
Other (OTH)
AF:
0.533
AC:
807
AN:
1514
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
996
1992
2988
3984
4980
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
540
1080
1620
2160
2700
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.547
Hom.:
4060
Bravo
AF:
0.503

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.95
CADD
Benign
1.5
DANN
Benign
0.47
PhyloP100
-0.15
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs5943427;
hg19: chrX-108973339;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.